USE OF ELSIGLUTIDE TO TREAT GASTROINTESTINAL MUCOSITIS INCLUDING CHEMOTHERAPY-INDUCED DIARRHEA

The invention relates to the use of elsiglutide to prevent or reduce the occurrence of gastrointestinal damage caused by chemotherapeutic agents, including gastrointestinal mucositis and chemotherapy-induced diarrhea (cid). L'invention concerne l'utilisation d'elsiglutide pour empêche...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SPEZIA, Riccardo, TRENTO, Fabio, KNUDSEN, Carsten Boye, CALCAGNILE, Selma, GIORGINO, Ruben, MORESINO, Cecilia, RONCORONI, Simona
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to the use of elsiglutide to prevent or reduce the occurrence of gastrointestinal damage caused by chemotherapeutic agents, including gastrointestinal mucositis and chemotherapy-induced diarrhea (cid). L'invention concerne l'utilisation d'elsiglutide pour empêcher ou réduire l'apparition de lésions gastro-intestinales provoquées par des agents chimiothérapeutiques, notamment la mucosité gastro-intestinale et la diarrhée induite par la chimiothérapie (cid).